PharmalogixPharmaceutical Knowledge PortalHomeHome
    • Overview
      • Overview
      • What is Medicinal Chemistry?
      • Scope of Medicinal Chemistry
      • Drug Discovery Process
      • Drug Targets
      • Hit Identification
      • Lead Identification
      • Lead Optimization (Overview)
      • ADMET
      • Drug Development Pipeline
      • ICH Guidelines and Regulatory Perspective
      • Overview
      • Rational Drug Design
      • Structure-Based Drug Design (SBDD)
      • Ligand-Based Drug Design (LBDD)
      • Computational Drug Design (CADD)
      • Protein Structure Retrieval (PDB)
      • Protein Preparation
      • Active Site Identification
      • Grid Box Generation
      • Ligand Preparation
      • Molecular Docking
      • Docking Score Interpretation
      • RMSD (Root-Mean-Square Deviation)
      • Binding Energy
      • Hydrogen Bond, Hydrophobic, and Electrostatic Interactions
      • Pharmacophore Modelling
      • Virtual Screening
      • Molecular Dynamics
      • ADMET Prediction (Computational)
      • Overview
      • Retrosynthetic Analysis
      • Synthetic Route Design
      • Reaction Mechanisms
      • Reaction Optimization
      • Solvent Selection
      • Catalyst Selection
      • Green Chemistry
      • Yield Optimization
      • Purification Techniques: General Principles
      • Recrystallization
      • Column Chromatography
      • Flash Chromatography
      • Preparative HPLC
      • Distillation
      • Liquid–Liquid Extraction
      • Overview
      • UV-Visible (UV-Vis) Spectroscopy
      • FTIR Spectroscopy
      • Nuclear Magnetic Resonance (NMR) Spectroscopy
      • Mass Spectrometry
      • HRMS (High-Resolution Mass Spectrometry)
      • LC–MS/MS
      • GC–MS
      • Structural Interpretation, Spectral Analysis, and Structure Confirmation
      • Overview
      • HPLC Purity
      • TLC Purity
      • Chiral Purity
      • Elemental Analysis
      • Karl Fischer Titration
      • Residual Solvents
      • Melting Point
      • ICH Q2(R2) Analytical Method Validation
      • Overview
      • Structure–Activity Relationship (SAR)
      • Bioisosteric Replacement
      • Functional Group Modification
      • Ring Modification
      • Lipophilicity Optimization
      • Electronic Effects
      • Steric Effects
      • Prodrug Design
      • Lead Optimization: Integrated Strategy
      • ADMET Optimization
      • Drug Metabolism Considerations
      • Patentability
      • Drug Candidate Selection
      • Career Opportunities in Medicinal Chemistry
      • Future Scope of Medicinal Chemistry
    • Overview
      • Overview
      • High Performance Liquid Chromatography (HPLC)
      • High Performance Thin Layer Chromatography (HPTLC)
      • UV-Visible Spectrophotometry
      • Gas Chromatography (GC) and GC-MS
      • LC-MS and LC-MS/MS
      • UPLC and UHPLC
      • FTIR and NIR Spectroscopy
      • ICH Guidelines: A Framework for Analytical Practice
      • Overview
      • Introduction to Bioanalysis and Regulatory Framework
      • Compound Understanding and Pre-Development Planning
      • Biological Matrix Selection and Sample Collection
      • Sample Preparation Method Development
      • Chromatographic and Mass Spectrometric Method Development
      • Full Method Validation under ICH M10
      • Incurred Sample Reanalysis
      • Pharmacokinetic Data Analysis and Reporting
      • Bioequivalence Studies: Design and Statistical Evaluation
      • Overview
      • Principles of Pharmaceutical Stability
      • Stability-Indicating Method Development and Validation
      • Design and Conduct of Stability Studies
      • Overview
      • Classification of Pharmaceutical Impurities
      • Regulatory Thresholds and Qualification
      • Analytical Strategies for Impurity Characterisation
      • Overview
      • Compendial Dissolution Apparatus
      • Dissolution Method Development
      • Biopharmaceutics Classification System and In Vitro-In Vivo Correlation
      • Overview
      • Principles of Data Integrity
      • Computer System Validation and Electronic Records
      • Overview
      • Principles and Rationale of Green Analytical Chemistry
      • Greenness Assessment Tools
    • Overview
      • Overview
      • What is Pharmaceutics?
      • Pharmaceutical Research Areas
      • Classification of Dosage Forms
      • Regulatory Frameworks Governing Pharmaceutics
      • The Pharmaceutical Formulation Research Workflow
      • Overview
      • Drug Physical Characterisation
      • Solubility and Dissolution Behaviour
      • pKa, LogP, LogD and Ionisation
      • Excipient Compatibility Studies
      • Biopharmaceutics Classification System
      • Overview
      • Quality by Design in Formulation Development
      • Solid Dosage Forms — Tablets and Capsules
      • Liquid Dosage Forms
      • Semi-Solid Dosage Forms
      • Parenteral Formulations
      • Overview
      • Nanoparticle Systems — PLGA, SLN, and NLC
      • Liposomes and Vesicular Carriers
      • Microspheres and Microparticles
      • SEDDS and SMEDDS — Self-Emulsifying Systems
      • Characterisation of Novel Drug Delivery Systems
      • Overview
      • ICH Q1A(R2) Stability Testing Conditions
      • Stability Protocols by Dosage Form
      • Degradation Kinetics
      • Shelf-Life Determination
      • Overview
      • Dissolution Testing under USP <711>
      • In-Vitro Release Testing — the Franz Diffusion Cell
      • Release Kinetics Modelling
      • BCS, IVIVC, and Bioequivalence
      • Overview
      • Tablet Manufacturing Troubleshooting
      • Novel Drug Delivery System Troubleshooting
      • Semi-Solid and Stability Troubleshooting
      • CTD Module 3 — Pharmaceutics Regulatory Documentation
      • Regulatory Landscape and Career Pathways
    • Overview
      • Overview
        • Overview
        • 1.4.1 Neuropharmacology
        • 1.4.2 Cardiovascular Pharmacology
        • 1.4.3 Chemotherapy (Anticancer and Anti-infective Pharmacology)
        • 1.4.4 Endocrine Pharmacology
        • 1.4.5 Toxicology
        • 1.4.6 Clinical Pharmacology
        • 1.4.7 Ethnopharmacology
        • 1.4.8 Molecular Pharmacology
        • Overview
        • 1.5.1 The Drug Discovery Process
        • 1.5.2 The Drug Development Pipeline: From Molecule to Market
        • Overview
        • 1.6.1 CPCSEA (India)
        • 1.6.2 CDSCO and Schedule Y
        • 1.6.3 OECD Guidelines
        • 1.6.4 ICH S-Series and M3(R2)
        • 1.6.5 US-FDA 21 CFR
        • 1.6.6 WHO and EMA
        • Overview
        • 1.7.1 What is GLP?
        • 1.7.2 Essential Elements of a GLP System
        • 1.7.3 GLP Documentation
        • 1.7.4 GLP Applications
      • Overview
        • Overview
        • 2.2.1 Target Identification
        • 2.2.2 Target Validation
        • Overview
        • 2.3.1 G-Protein-Coupled Receptors (GPCRs)
        • 2.3.2 Ion Channels
        • 2.3.3 Enzymes
        • 2.3.4 Nuclear Receptors
        • 2.3.5 Transporter Proteins
        • 2.3.6 Kinases
        • 2.3.7 DNA and RNA
        • 2.3.8 Structural Proteins
        • Overview
        • 2.6.1 Absorption
        • 2.6.2 Distribution
        • 2.6.3 Metabolism
        • 2.6.4 Excretion
        • 2.6.5 Toxicity (In-Silico)
        • 2.6.6 Computational Tools
        • Overview
        • 2.7.1 In-Silico Screening
        • 2.7.2 Molecular Docking
        • 2.7.3 Bioinformatics in Target and Compound Research
      • Overview
        • Overview
        • 3.2.1 Commonly Used Cell Lines in Pharmacology Research
        • 3.2.2 Cell Culture Good Practice
        • Overview
        • 3.4.1 Principle of Enzyme Inhibition Kinetics
        • 3.4.2 Representative Target Enzymes and Assay Methods
        • Overview
        • 3.6.1 Antimicrobial Assays
        • 3.6.2 Antioxidant Assays
        • Overview
        • 3.7.1 Assay Quality Metrics in HTS
        • 3.7.2 From Primary Hit to Confirmed Hit
      • Overview
        • Overview
        • 4.2.1 CPCSEA Registration and IAEC Composition
        • 4.2.2 Protocol Submission and the 3Rs Principle
        • Overview
        • 4.5.1 Routes of Administration
        • 4.5.2 Human-to-Animal Dose Conversion
        • Overview
        • 4.9.1 Central Nervous System and Behavioural Disease Models
        • 4.9.2 Cardiovascular Disease Models
        • 4.9.3 Metabolic and Endocrine Disease Models
        • 4.9.4 Inflammatory, Immunological, and Pain Models
        • 4.9.5 Oncology Models
        • 4.9.6 Organ Toxicity Models
        • 4.9.7 Respiratory Disease Models
        • 4.9.8 Gastrointestinal Disease Models
        • 4.9.9 Dermatological and Wound Models
        • 4.9.10 Infectious Disease Models
        • 4.9.11 General Toxicological Screening Models
      • Overview
        • Overview
        • 5.2.1 OECD Test Guideline 423 — Acute Toxic Class Method (ATM)
        • 5.2.2 OECD Test Guideline 425 — Up-and-Down Procedure (UDP)
        • Overview
        • 5.5.1 Sub-Chronic Toxicity (90-Day)
        • 5.5.2 Chronic Toxicity (12 Months or Longer)
        • 5.5.3 Carcinogenicity
        • 5.5.4 Reproductive and Developmental Toxicity
      • Overview
        • Overview
        • 6.4.1 Assumptions Underlying Parametric Tests
        • 6.4.2 One-Way ANOVA Workflow in GraphPad Prism
        • Overview
        • 6.5.1 The Mann-Whitney U Test and Wilcoxon Signed-Rank Test
        • 6.5.2 The Kruskal-Wallis Test
        • Overview
        • 6.6.1 Correlation
        • 6.6.2 Regression
        • Overview
        • 6.7.1 The Four-Parameter Logistic (4PL) Model
        • 6.7.2 Pharmacological Dose-Response Parameters
        • Overview
        • 6.9.1 Why Power Analysis is Mandatory
        • Overview
        • 6.10.1 Prism Table Types and Their Applications
      • Overview
        • Overview
        • 7.6.1 Publication Ethics
        • 7.6.2 Plagiarism
        • 7.6.3 Research Integrity
    • Overview
      • Overview
      • Learning Objectives
        • Overview
        • 1.4.1 Macroscopic (Organoleptic) Authentication
        • 1.4.2 Microscopic Authentication (Histological Evaluation)
        • 1.4.3 Molecular Authentication: DNA Barcoding
        • 1.4.4 Chemical Authentication: Chromatographic Fingerprinting
        • Overview
        • Frequently Asked Questions
        • Common Interview and Viva Questions
        • Common Mistakes and Troubleshooting
      • Overview
      • Learning Objectives
        • Overview
        • 2.2.1 Maceration (Cold Extraction)
        • 2.2.2 Soxhlet Extraction (Continuous Hot Extraction)
        • 2.2.3 Sequential Extraction by Polarity Gradient
        • Overview
        • 2.5.1 Column Chromatography
        • 2.5.2 Flash Chromatography and Preparative HPLC
        • Overview
        • Frequently Asked Questions
        • Common Interview and Viva Questions
        • Common Mistakes and Troubleshooting
      • Overview
      • Learning Objectives
        • Overview
        • 3.3.1 Thin-Layer Chromatography (TLC) Fingerprinting
        • 3.3.2 High-Performance Thin-Layer Chromatography (HPTLC) Fingerprinting
        • 3.3.3 High-Performance Liquid Chromatography (HPLC) Marker Quantification
        • Overview
        • Frequently Asked Questions
        • Common Interview and Viva Questions
        • Common Mistakes and Troubleshooting
      • Overview
      • Learning Objectives
        • Overview
        • Frequently Asked Questions
        • Common Interview and Viva Questions
        • Common Mistakes and Troubleshooting
      • Overview
      • Learning Objectives
        • Overview
        • Frequently Asked Questions
        • Common Interview and Viva Questions
        • Common Mistakes and Troubleshooting
      • Overview
      • Learning Objectives
        • Overview
        • Frequently Asked Questions
        • Common Interview and Viva Questions
        • Common Mistakes and Troubleshooting
    • Overview
    • Books
    • Guidelines
    • Research Papers
    • Downloads
Resources
Downloads

Downloads

Place downloadable documents in /public/downloads and link them from this page or from article pages.

PDFMethod Validation Protocol TemplateTemplate placeholder for analytical validation documentation. PDFHerbal Specification TemplateTemplate placeholder for botanical raw material specifications. PDFStability Study ChecklistChecklist placeholder for stability protocol setup and review.
Research Papers
© 2026 Pharmalogix. Educational and professional reference portal.